Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study
- PMID: 19319131
- PMCID: PMC2714477
- DOI: 10.1038/ajg.2009.137
Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study
Abstract
Objectives: Our aim was to measure the relative risks of Barrett's esophagus (BE) associated with demographic factors, measures of adiposity, and smoking among patients with gastroesophageal reflux disease (GERD).
Methods: Patients newly diagnosed with specialized intestinal metaplasia (SIM) (n=197) were compared with patients with GERD (n=418) in a community clinic-based case-control study. Case subgroups included those with any visible columnar epithelium (VBE) (n=97), and those with a long segment (>or=2 cm) of columnar epithelium (LSBE) (n=54).
Results: Risks increased with older age (adjusted odds ratio (aOR) per decade for SIM=1.3, 95% confidence interval (CI)=1.1-1.5; VBE aOR=1.4, CI=1.1-1.6; LSBE aOR=1.5, CI=1.2-1.9), male gender (SIM aOR=1.5, CI=1.1-2.2; VBE aOR=2.7, CI=1.6-4.5; LSBE aOR=3.9, CI=1.9-8.1), and possibly Asian race. Increased risk of BE was observed with high waist-to-hip ratio (WHR, male high: >or=0.9, female high: >or=0.8) (SIM aOR=1.3, CI=0.9-2.1; VBE aOR=1.9, CI=1.0-3.5; LSBE aOR=4.1, CI=1.5-11.4). These associations were independent of body mass index (BMI) for the VBE and LSBE case groups but not for SIM, which was the only case group in which BMI was a significant risk factor. Ever having smoked cigarettes increased risk similarly for all case groups (SIM aOR=1.8, CI=1.2-2.6; VBE aOR=1.6, CI=1.0-2.6; LSBE aOR=2.6, CI=1.3-4.9), although a dose-response relationship was not detected for duration or intensity of smoking.
Conclusions: Older age, male gender, and history of smoking increased risk of SIM and BE among GERD patients independent of other risk factors for BE. Central adiposity was most strongly related to risk of VBE and LSBE. These results may be useful in the development of risk profiles for screening GERD patients.
Conflict of interest statement
Figures
Similar articles
-
Central adiposity and risk of Barrett's esophagus.Gastroenterology. 2007 Aug;133(2):403-11. doi: 10.1053/j.gastro.2007.05.026. Epub 2007 May 21. Gastroenterology. 2007. PMID: 17681161
-
The frequency of Barrett's esophagus in high-risk patients with chronic GERD.Gastrointest Endosc. 2005 Feb;61(2):226-31. doi: 10.1016/s0016-5107(04)02589-1. Gastrointest Endosc. 2005. PMID: 15729230
-
Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus.Am J Gastroenterol. 2010 Aug;105(8):1729, 1730-7; quiz 1738. doi: 10.1038/ajg.2010.194. Epub 2010 May 18. Am J Gastroenterol. 2010. PMID: 20485283 Free PMC article. Review.
-
Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.Am J Gastroenterol. 2002 Mar;97(3):554-60. doi: 10.1111/j.1572-0241.2002.05529.x. Am J Gastroenterol. 2002. PMID: 11922546
-
The characteristics of Barrett's esophagus: an analysis of 4120 cases in China.Dis Esophagus. 2009;22(4):348-53. doi: 10.1111/j.1442-2050.2008.00924.x. Epub 2009 Jan 23. Dis Esophagus. 2009. PMID: 19191861 Review.
Cited by
-
Barrett's oesophagus: Current controversies.World J Gastroenterol. 2017 Jul 28;23(28):5051-5067. doi: 10.3748/wjg.v23.i28.5051. World J Gastroenterol. 2017. PMID: 28811703 Free PMC article. Review.
-
Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.Gastroenterology. 2012 Apr;142(4):744-53. doi: 10.1053/j.gastro.2011.12.049. Epub 2012 Jan 11. Gastroenterology. 2012. PMID: 22245667 Free PMC article.
-
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis.Nat Rev Cancer. 2010 Feb;10(2):87-101. doi: 10.1038/nrc2773. Nat Rev Cancer. 2010. PMID: 20094044 Free PMC article. Review.
-
A clinical risk prediction model for Barrett esophagus.Cancer Prev Res (Phila). 2012 Sep;5(9):1115-23. doi: 10.1158/1940-6207.CAPR-12-0010. Epub 2012 Jul 11. Cancer Prev Res (Phila). 2012. PMID: 22787114 Free PMC article.
-
Barrett's esophagus: a review of the literature.J Gastrointest Surg. 2011 May;15(5):708-18. doi: 10.1007/s11605-011-1485-y. Epub 2011 Apr 2. J Gastrointest Surg. 2011. PMID: 21461873 Review.
References
-
- Heikkinen TJ, Haukipuro K, Koivukangas P, Sorasto A, Autio R, Sodervik H, Makela H, Hulkko A. Comparison of costs between laparoscopic and open Nissen fundoplication: a prospective randomized study with a 3-month followup. J Am.Coll.Surg. 1999 Apr;188(4):368–376. - PubMed
-
- Myrvold HE, Lundell L, Miettinen P, Pedersen SA, Liedman B, Hatlebakk J, Julkunen R, Levander K, Lamm M, Mattson C, et al. The cost of long term therapy for gastro-oesophageal reflux disease: a randomised trial comparing omeprazole and open antireflux surgery. Gut. 2001 Oct;49(4):488–494. - PMC - PubMed
-
- Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C, Gemmen E, Shah S, Avdic A, Rubin R. The burden of selected digestive diseases in the United States. Gastroenterology. 2002 May;122(5):1500–1511. - PubMed
-
- Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am.J Gastroenterol. 2000 Aug;95(8):1881–1887. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical